期刊文献+

保乳手术与改良根治术治疗早期乳腺癌近远期疗效对比 被引量:11

Comparison of recent and long-term effect on breast-conserving therapy and modified radical mastectomy in the treatment of the early-stage breast cancer
在线阅读 下载PDF
导出
摘要 目的:探讨保乳手术和改良根治术治疗早期乳腺癌的近远期疗效。方法:回顾性分析2002年12月~2007年12月我科诊治70例Ⅰ、Ⅱ期乳腺癌患者的临床资料,根据手术方式分为保乳手术组(BCT组)和改良根治术组(MRM组),比较两组患者术后疗效和生存质量的差异。结果:BCT组患者术后皮下积液、患侧上肢水肿和皮瓣坏死发生率低于MRM组,其中在皮下积液方面比较,差异有统计学意义(P<0.05)。BCT组无患者因相关疾病死亡(0),3年存活率为100.0%,术后局部复发4例(11.4%),远处转移3例(8.6%);MRM组随访结束时1例患者死亡(2.9%),3年存活率为97.1%,术后局部复发5例(14.3%),远处转移4例(11.4%)。BCT组和MRM组患者在死亡率、3年存活率、局部复发和远处转移方面差异无统计学意义(P>0.05)。BCT组术后随访的美容效果优、良率和生存质量评分均显著高于MRM组,差异有高度统计学意义(P<0.001)。结论:保乳手术治疗早期乳腺癌术后并发症少,患者生存质量高,近远期疗效显著高于改良根治术。 Objective: To explore the recent and long-term effect on breast-conserving therapy and modified radical mastectomy in the treatment of the early-stage breast cancer.Methods: The data of 70 cases of patients with early-stage breast cancer of grade Ⅰ,Ⅱ from December 2002 to December 2007 were retrospectively analyzed and divided into BCT group and MRM group according to their surgical method.The curative effects and quality of life were compared.Results: The incidence of subcutaneous fluid,ipsilateral upper extremity edema,flap necrosis in BCT group was lower than that of MRM group,there was a significant difference in the subcutaneous fluid(P0.05).No patient died due to associated diseases(0),the survival rate of three years was 100.0%,local recurrence after surgery was 4 cases(11.4%),distant metastasis was 3 cases(8.6%);1 patient died due to associated diseases(2.9%),the survival rate of three years was 97.1%,local recurrence after surgery was 5 cases(14.3%),distant metastasis was 4 cases(11.4%).There was no significant difference between the two groups in survival rate,mortality rate and local recurrence rate(P0.05).Postoperative cosmetic and quality of life in BCT group were significantly higher than those in MRM group(P0.001).Conclusion: The recent and long-term effect of BCT for the patients with early-stage breast cancer is effective with few complications and high quality of life,which are better than MRM.
出处 《中国医药导报》 CAS 2011年第35期41-42,共2页 China Medical Herald
关键词 乳腺癌 保乳手术 改良根治术 Breast cancer Breast-conserving therapy Modified radical mastectomy
  • 相关文献

参考文献7

二级参考文献71

  • 1张保宁.乳腺癌保乳手术的研究进展[J].中国普外基础与临床杂志,2005,12(3):204-206. 被引量:103
  • 2徐兵河,孙燕.早期乳腺癌术后辅助治疗的现状与展望[J].临床肿瘤学杂志,2006,11(4):241-246. 被引量:8
  • 3Bonadonna G, Brusamolion E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med, 1976, 294:405-410.
  • 4Bonadonna G, Moliterni A, Zambetti M, et al. 30 years' follow up of randomized studies of adjuvant CMF in operable breast cancer: cohort study. BMJ, 2005, 330:217-220.
  • 5Early Breast Cancer Trialist's Collaborative Group. Polychemotherapy for early breast cancer. An overview of the randomized trials.Lancet, 1998, 352(9132) :930-932.
  • 6Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomided trials. Lancet, 1998,351 : 1451-1467.
  • 7Fisher B, Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen for lymph node-negative breast cancers: updated finding from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. J Natl Cancer Inst, 2001, 93:684-690.
  • 8Ingle JN, Dowsett M, Cuzick J, et al. Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies. Cancer Res, 2009, 69 Suppl 2:66s.
  • 9Pritchard KI, Shepherd LE, O'MaUey FP, et al. HER-2 and responsiveness of breast cancer to adjuvant chemotherapy. N Engl J Med, 2006, 354:2103-2111.
  • 10Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer:Clinical features and patterns of recurrence. Clin Cancer Res, 2007, 13:4429-4434.

共引文献693

同被引文献85

引证文献11

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部